Clinical Trial Update: Effect of Melatonin in Pediatric Hemodialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of melatonin in pediatric patients undergoing hemodialysis, focusing on complications, oxidative stress, and inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hemodialysis-associated Complications

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Ain Shams University | Conditions: Hemodialysis Complication, Oxidative Stress | Phase 3 | Status: UNKNOWN